Michael James Morrissey - Apr 1, 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Role: EVP, Head of Tech. Operations
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Stock symbol: INCY
Transactions as of: Apr 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/3/2025, 04:51 PM
Previous filing: Feb 3, 2025
Next filing: Jul 17, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INCY	Common Stock	Award	$0	+4.65K	+5.7%	$0.00	86.2K	Apr 1, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on April 1, 2025. The earned shares will vest on November 30, 2025, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, achievement of specified Opzelura performance goals. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded.
F2	Includes an aggregate of 32,156 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Content

Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on April 1, 2025. The earned shares will vest on November 30, 2025, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, achievement of specified Opzelura performance goals. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded.

Includes an aggregate of 32,156 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.